Radhika McDonald
Family · Inverness, FLNPI 1033973334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 90.9% of the total across 164 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 40 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $22.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$370
- Astellas Pharma US Inc$340
- Merck$246
- Gilead$225
- Johnson & Johnson$217
- E.r. Squibb & Sons, L.L.C.$174
- plus $2K from 34 others
What the payments were for
- Food & beverage$3,31091%
- Education$3339%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 24 | $370 |
| Astellas Pharma US Inc | 7 | $340 |
| Merck | 12 | $246 |
| Gilead | 10 | $225 |
| Johnson & Johnson | 10 | $217 |
| E.r. Squibb & Sons, L.L.C. | 9 | $174 |
| Sobi, Inc | 5 | $164 |
| GSK | 7 | $161 |
| Pfizer | 7 | $148 |
| Eisai Inc. | 7 | $133 |
| Sanofi | 4 | $115 |
| Bayer | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $108 |
| Regeneron Healthcare Solutions, Inc. | 4 | $102 |
| AstraZeneca(2 entities) | 5 | $96 |
| Incyte Corporation | 4 | $84 |
| EMD Serono, Inc. | 4 | $80 |
| Lilly USA, LLC | 3 | $77 |
| Daiichi Sankyo Inc. | 4 | $76 |
| Puma Biotechnology, Inc. | 3 | $63 |
| Jazz Pharmaceuticals Inc. | 3 | $52 |
| Novocure Inc. | 1 | $42 |
| Boehringer Ingelheim | 2 | $41 |
| AbbVie | 2 | $41 |
| Ipsen Biopharmaceuticals, Inc | 2 | $40 |
| Pharmacosmos Therapeutics Inc. | 2 | $37 |
| Sun Pharmaceutical Industries Inc. | 1 | $30 |
| ADC Therapeutics America, Inc. | 1 | $26 |
| Taiho Oncology, Inc. | 1 | $26 |
| Acrotech Biopharma Inc. | 1 | $26 |
| Legend Biotech USA Inc. | 1 | $23 |
| Dendreon Pharmaceuticals LLC | 1 | $22 |
| Mirati Therapeutics, Inc. | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| Stemline Therapeutics Inc. | 1 | $19 |
| Karyopharm Therapeutics Inc. | 1 | $19 |
| Servier Pharmaceuticals LLC | 1 | $19 |
| AVEO Pharmaceuticals, Inc. | 1 | $18 |
| Corcept Therapeutics | 1 | $18 |
| Teleflex LLC | 1 | $17 |
How this compares
$3,642 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Other family in Inverness
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.